Tioga Cardiovascular
PrivateLast Round
VC Round
Sep 16, 2025
Total Funding Raised
$75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tioga Cardiovascular operates in Healthcare & Life Sciences and is based in Los Gatos, California. Its latest recorded funding round was a VC Round in September 2025.
Tioga Cardiovascular is a medical device company that develops innovative transcatheter valve replacement solutions for mitral and tricuspid applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tioga Cardiovascular Comparables
Compare Tioga Cardiovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnovHeart | 91% | |
| 4C Medical Technologies, Inc. | 89% | |
| HighLife Medical | 89% |
For institutional investors. Book with your work email.
Tioga Cardiovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 16, 2025 | ||||
| Series C | Feb 9, 2023 | ||||
| Series B | Jul 7, 2021 | ||||
| Series A | Apr 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tioga Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shifamed | Series C, Series B |
| Cormorant Asset Management | Series A, Series B, Series C |
| The Capital Partnership | Series C, Series A, Series B |
| PA MedTech VC Fund | Series C |
| ShangBay Capital | Series A |
| AMED Ventures | Series C, Series A, Series B |
| Cormorant Asset Management | Series A, Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 50% MoM, reaching 1.4K.
- Jul 25, 2026
Monthly visitors increased 45% MoM.
For institutional investors. Book with your work email.
Tioga Cardiovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tioga Cardiovascular's valuation, stock price, and market status.
Is Tioga Cardiovascular a public or private company?
Tioga Cardiovascular is a private company.
What is the current stock price of Tioga Cardiovascular?
Tioga Cardiovascular is a private company, so its shares have no public market price. Caplight tracks Tioga Cardiovascular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tioga Cardiovascular worth (valuation)?
Valuation information for Tioga Cardiovascular is not publicly available.
Can I buy Tioga Cardiovascular stock?
Tioga Cardiovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tioga Cardiovascular's last funding round?
Tioga Cardiovascular's most recent funding round was VC Round on September 16, 2025.
Who are the main investors in Tioga Cardiovascular?
Key investors in Tioga Cardiovascular include Cormorant Asset Management, The Capital Partnership, Cormorant Asset Management.
Will Tioga Cardiovascular IPO soon?
No public IPO plans have been announced for Tioga Cardiovascular.
How can I track Tioga Cardiovascular secondary market activity?
Caplight tracks bids, offers, and trades in Tioga Cardiovascular's shares on secondary markets.